Four major themes cover the research activities in Rémi Quirion's laboratory.

Lab members of the Remi Quirion laboratory.

The laboratory evaluates the safety and effectiveness of an investigational drug aimed at slowing the progression of Alzheimer's Disease.

Apart from the drugs, some other therapies have proved successful to slow the onset of Alzheimer's symptoms.

Alzheimer's Disease : Causes, symptoms and evolution

We all know that, as a population, we are getting older: By 2016, 17% of Canadians will be at least 65 years old and, as the population ages, the number of Alzheimer’s cases will rise accordingly (Statistics Canada) The risk of depression among caregivers of Alzheimer’s sufferers is twice as high as for informal caregivers of individuals with no dementia The needs of our aging population will be a heavy load to bear if we do not find more effective means to treat and prevent ...

Dr Rosa-Neto's work is among projects awarded new funds by CQDM, Brain Canada and the Ontario Brain Institute (OBI).

For Easter season, researchers at the Douglas Mental Health University Institute have some advice: drink red wine (with moderation), black or green tea and eat chocolate. Their findings summarized in the June 2007 Neurochemical Research, describe

The Douglas Institute is part of an international effort to investigate a new treatment A vaccine-based approach could be an effective therapy for people with mild or moderate forms of Alzheimer’s disease. The medication used for this therapy w

Douglas study evaluates beneficial properties of green and black teas Tea may be more than a trendy coffee alternative, according to researchers at the Douglas Hospital Research Centre (DHRC). Their findings, published in a recent issue of the Eur